HIV prevention shot achieved a 96% success rate in clinical trials, but accessibility and regulatory hurdles remain a ...
The spread of disease, as well as delays to the development of vaccines and new treatments, could be affected by cuts to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback